Fabre Kramer Drug Patent Portfolio

Fabre Kramer owns 1 orange book drug protected by 1 US patent Given below is the list of Fabre Kramer's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7538116 Treatment of sexual disorders 02 Sep, 2025
Active


Given below is the list of recent legal activities going on the following drug patents of Fabre Kramer.

Activity Date Patent Number
Patent litigations
Second letter to regulating agency to determine regulatory review period 14 Mar, 2024 US7538116
Letter from FDA or Dept of Agriculture re PTE application 06 Feb, 2024 US7538116
Initial letter Re: PTE Application to regulating agency 21 Nov, 2023 US7538116
Patent Term Extension Application under 35 USC 156 Filed 16 Nov, 2023 US7538116
Payment of Maintenance Fee, 12th Yr, Small Entity 25 Sep, 2020 US7538116
Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 05 Sep, 2019 US7538116
Patent Issue Date Used in PTA Calculation 26 May, 2009 US7538116
Recordation of Patent Grant Mailed 26 May, 2009 US7538116
Email Notification 07 May, 2009 US7538116
Issue Notification Mailed 06 May, 2009 US7538116
Dispatch to FDC 14 Apr, 2009 US7538116
Application Is Considered Ready for Issue 14 Apr, 2009 US7538116
Issue Fee Payment Received 13 Apr, 2009 US7538116
Issue Fee Payment Verified 13 Apr, 2009 US7538116
Mail Notice of Allowance 12 Jan, 2009 US7538116


Fabre Kramer's Family Patents


Family Patents



Fabre Kramer Drug List

Given below is the complete list of Fabre Kramer's drugs and the patents protecting them.


1. Exxua

Exxua is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7538116 Treatment of sexual disorders 02 Sep, 2025
(10 months from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Exxua's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List